AMED logo

Amedisys (AMED) Return On Equity

Annual ROE

3.76%
+4.64%+527.27%

December 31, 2024

Summary

Performance

1-Year Change

+527.27%

3-Year Change

-83.93%

5-Year Change

-83.34%

15-Year Change

-39.35%

AMED ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

73.46%
AMED annual return on equity is higher than 73.46% of companies in Healthcare sector

High & Low

All-time High

212.86%
AMED annual return on equity is currently -98.23% below its historical high of 212.86%

3-Year Low

-0.88%

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
AMED previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
AMED next annual earnings announcement has not yet been scheduled

OtherAMEDprofitabilitymetrics:

Annual Revenue

$2.35 B
AMED annual revenue is $2.35 billion

Annual Net Income

$43.23 M
AMED annual net profit is $43.23 million

Annual EPS

$1.31
AMED annual earnings per share is $1.31

Annual ROA

2.06%
AMED annual return on assets is 2.06%

Quarterly ROE

3.71%
-3.52%-48.69%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+521.59%

3-Year Change

+521.59%

5-Year Change

+521.59%

AMED Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

73.5%
AMED quarterly return on equity is higher than 73.5% of companies in Healthcare sector

High & Low

All-time High

1061.41%
AMED quarterly return on equity is currently -99.65% below its historical high of 1061.41%

3-Year Low

-1.86%

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
AMED previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

Apr 24, 2025
AMED next earnings announcement is scheduled for Apr 24, 2025

OtherAMEDprofitabilitymetrics:

Quarterly Revenue

$598.05 M
AMED quarterly revenue is $598.05 million

Quarterly Net Income

-$20.38 M
AMED quarterly net profit is -$20.38 million

Quarterly EPS

-$0.62
AMED quarterly earnings per share is -$0.62

Quarterly ROA

2.05%
AMED quarterly return on assets is 2.05%

ROE Formula

ROE =  Net Income
Shareholders Equity ✕ 100%

Annual ROE

3.76%
AMED annual return on equity is 3.76%

Annual Net Income

$43.23 M
AMED annual net profit is $43.23 million

Annual Shareholders Equity

$1.13 B
AMED annual stockholders equity is $1.13 billion

AMED ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+527.3%+521.6%
3 y3 years-83.9%+521.6%
5 y5 years-83.3%+521.6%

AMED ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-83.9%+527.3%-84.4%+299.5%
5 y5-year-85.1%+527.3%-88.1%+299.5%
alltimeall time-98.2%+104.5%-99.7%+100.0%

Amedisys ROE History

DateAnnualQuarterly
Dec 2024
3.76%(-527.3%)
3.71%(-48.7%)
Sep 2024
-
7.23%(-12.0%)
Jun 2024
-
8.22%(-541.9%)
Mar 2024
-
-1.86%(+111.4%)
Dec 2023
-0.88%(-107.7%)
-0.88%(-466.7%)
Sep 2023
-
0.24%(+9.1%)
Jun 2023
-
0.22%(-97.9%)
Mar 2023
-
10.45%(-8.2%)
Dec 2022
11.39%(-51.3%)
11.38%(-4.8%)
Sep 2022
-
11.96%(-17.1%)
Jun 2022
-
14.43%(-30.3%)
Mar 2022
-
20.70%(-12.8%)
Dec 2021
23.40%(-7.5%)
23.75%(-9.8%)
Sep 2021
-
26.32%(-15.7%)
Jun 2021
-
31.24%(+16.5%)
Mar 2021
-
26.82%(+5.5%)
Dec 2020
25.29%(+12.1%)
25.41%(+4.2%)
Sep 2020
-
24.39%(+22.1%)
Jun 2020
-
19.98%(-5.6%)
Mar 2020
-
21.16%(-6.2%)
Dec 2019
22.57%(-5.5%)
22.55%(-6.9%)
Sep 2019
-
24.21%(-5.4%)
Jun 2019
-
25.58%(-0.2%)
Mar 2019
-
25.64%(+3.3%)
Dec 2018
23.89%(+285.3%)
24.83%(+37.3%)
Sep 2018
-
18.09%(+26.1%)
Jun 2018
-
14.35%(+73.3%)
Mar 2018
-
8.28%(+34.9%)
Dec 2017
6.20%(-27.5%)
6.14%(-31.6%)
Sep 2017
-
8.98%(+3.9%)
Jun 2017
-
8.64%(-16.6%)
Mar 2017
-
10.36%(+19.9%)
Dec 2016
8.55%(-1240.0%)
8.64%(-12.5%)
Sep 2016
-
9.87%(+4.3%)
Jun 2016
-
9.46%(-2.8%)
Mar 2016
-
9.73%(-1363.6%)
Dec 2015
-0.75%(-122.6%)
-0.77%(-56.5%)
Sep 2015
-
-1.77%(-1.1%)
Jun 2015
-
-1.79%(-31.4%)
Mar 2015
-
-2.61%(-177.2%)
Dec 2014
3.32%(-114.3%)
3.38%(-311.3%)
Sep 2014
-
-1.60%(-94.1%)
Jun 2014
-
-27.06%(-0.8%)
Mar 2014
-
-27.27%(+20.9%)
Dec 2013
-23.27%(+35.6%)
-22.56%(-45.6%)
Sep 2013
-
-41.48%(+124.0%)
Jun 2013
-
-18.52%(+9.8%)
Mar 2013
-
-16.87%(+5.6%)
Dec 2012
-17.16%(-68.6%)
-15.97%(-410.1%)
Sep 2012
-
5.15%(-107.7%)
Jun 2012
-
-66.94%(+15.9%)
Mar 2012
-
-57.76%(+13.1%)
Dec 2011
-54.64%(-492.2%)
-51.05%(+13.5%)
Sep 2011
-
-44.99%(-582.2%)
Jun 2011
-
9.33%(-15.5%)
Mar 2011
-
11.04%(-23.2%)
Dec 2010
13.93%(-33.4%)
14.38%(-12.4%)
Sep 2010
-
16.41%(-15.4%)
Jun 2010
-
19.39%(-8.1%)
Mar 2010
-
21.09%(+0.1%)
Dec 2009
20.92%
21.06%(+2.2%)
DateAnnualQuarterly
Sep 2009
-
20.61%(+4.2%)
Jun 2009
-
19.78%(+8.0%)
Mar 2009
-
18.31%(+5.8%)
Dec 2008
17.17%(+7.0%)
17.30%(+6.3%)
Sep 2008
-
16.27%(-1.3%)
Jun 2008
-
16.48%(+2.4%)
Mar 2008
-
16.10%(-0.3%)
Dec 2007
16.04%(+16.7%)
16.15%(-2.7%)
Sep 2007
-
16.60%(+5.5%)
Jun 2007
-
15.74%(-0.8%)
Mar 2007
-
15.86%(+0.1%)
Dec 2006
13.75%(-22.1%)
15.85%(-4.9%)
Sep 2006
-
16.67%(+2.3%)
Jun 2006
-
16.30%(-2.4%)
Mar 2006
-
16.70%(-5.5%)
Dec 2005
17.65%(-14.0%)
17.67%(-2.3%)
Sep 2005
-
18.08%(-6.5%)
Jun 2005
-
19.33%(-5.8%)
Mar 2005
-
20.52%(-7.4%)
Dec 2004
20.52%(-16.6%)
22.16%(-15.2%)
Sep 2004
-
26.12%(-23.2%)
Jun 2004
-
33.99%(+3.4%)
Mar 2004
-
32.87%(+4.7%)
Dec 2003
24.60%(+232.4%)
31.38%(-707.0%)
Sep 2003
-
-5.17%(-53.9%)
Jun 2003
-
-11.21%(-8.6%)
Mar 2003
-
-12.26%(+44.9%)
Dec 2002
7.40%(-95.5%)
-8.46%(-112.8%)
Sep 2002
-
66.14%(-54.7%)
Jun 2002
-
145.85%(-64.2%)
Mar 2002
-
407.59%(-61.6%)
Dec 2001
162.77%(-295.2%)
1061.41%(-195.1%)
Sep 2001
-
-1116.25%(+408.0%)
Jun 2001
-
-219.73%(+106.8%)
Mar 2001
-
-106.24%(+183.6%)
Dec 2000
-83.39%(+553.5%)
-37.46%(-231.7%)
Sep 2000
-
28.44%(+25.8%)
Jun 2000
-
22.60%(-100.1%)
Mar 2000
-
-21.12 K%(+416.1%)
Dec 1999
-12.76%(-106.0%)
-
Mar 1999
-
-4091.80%(+563.9%)
Dec 1998
212.86%(-1238.9%)
-616.32%(+353.1%)
Sep 1998
-
-136.01%(+72.8%)
Jun 1998
-
-78.72%(+42.2%)
Mar 1998
-
-55.35%(+184.4%)
Dec 1997
-18.69%(-4550.0%)
-19.46%(-353.1%)
Sep 1997
-
7.69%(+20.7%)
Jun 1997
-
6.37%(+36.7%)
Mar 1997
-
4.66%(+79.9%)
Dec 1996
0.42%(-98.5%)
2.59%(-83.4%)
Sep 1996
-
15.63%(-25.7%)
Jun 1996
-
21.03%(-0.1%)
Mar 1996
-
21.05%(+0.4%)
Dec 1995
27.69%(-626.4%)
20.96%(+8.3%)
Sep 1995
-
19.35%(+78.5%)
Jun 1995
-
10.84%(+142.0%)
Mar 1995
-
4.48%(-145.5%)
Sep 1994
-
-9.84%(-33.3%)
Jun 1994
-
-14.75%(+43.8%)
Mar 1994
-
-10.26%(+95.1%)
Dec 1993
-5.26%
-5.26%

FAQ

  • What is Amedisys annual return on equity?
  • What is the all time high annual ROE for Amedisys?
  • What is Amedisys annual ROE year-on-year change?
  • What is Amedisys quarterly return on equity?
  • What is the all time high quarterly ROE for Amedisys?
  • What is Amedisys quarterly ROE year-on-year change?

What is Amedisys annual return on equity?

The current annual ROE of AMED is 3.76%

What is the all time high annual ROE for Amedisys?

Amedisys all-time high annual return on equity is 212.86%

What is Amedisys annual ROE year-on-year change?

Over the past year, AMED annual return on equity has changed by +4.64% (+527.27%)

What is Amedisys quarterly return on equity?

The current quarterly ROE of AMED is 3.71%

What is the all time high quarterly ROE for Amedisys?

Amedisys all-time high quarterly return on equity is 1061.41%

What is Amedisys quarterly ROE year-on-year change?

Over the past year, AMED quarterly return on equity has changed by +4.59% (+521.59%)